Torrent Pharmaceuticals Limited Cash Flow Conversion Efficiency

Latest as of September 2025: 0.123x

Torrent Pharmaceuticals Limited cash flow conversion efficiency. Based on the latest financial reports, Torrent Pharmaceuticals Limited (TORNTPHARM) has a cash flow conversion efficiency ratio of 0.123x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs10.38 Billion ≈ $112.26 Million USD) by net assets (Rs84.49 Billion ≈ $913.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Torrent Pharmaceuticals Limited (2005–2026)

Cash flow conversion efficiency of Torrent Pharmaceuticals Limited from 2005 to 2026. This chart illustrates how Torrent Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Torrent Pharmaceuticals Limited for real-time trading data and today's change.

Torrent Pharmaceuticals Limited Cash Flow Conversion Ratio Explained

Torrent Pharmaceuticals Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Torrent Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Torrent Pharmaceuticals Limited ranked by their cash flow conversion efficiency. Also see Torrent Pharmaceuticals Limited market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Qingdao Haier Co Ltd SHG:600690	0.064x
Centrais Electricas Brasileiras SA NYSE:EBR	0.039x
China Shenhua Energy Company Limited F:IKF	0.031x
Krung Thai Bank Public Company Limited BK:KTB	0.286x
Bank Polska Kasa Opieki SA WAR:PEO	0.040x
Repsol S.A. MC:REP	0.048x
Telenor ASA OL:TEL	0.219x
Synnex Corporation NYSE:SNX	-0.030x

Annual Cash Flow Conversion Efficiency for Torrent Pharmaceuticals Limited (2005–2026)

The table below shows the annual cash flow conversion efficiency of Torrent Pharmaceuticals Limited from 2005 to 2026. Review TORNTPHARM free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs175.85 Billion ≈ $1.90 Billion	Rs26.32 Billion ≈ $284.64 Million	0.150x	-56.05%
2025-03-31	Rs75.91 Billion ≈ $820.94 Million	Rs25.85 Billion ≈ $279.56 Million	0.341x	-28.51%
2024-03-31	Rs68.56 Billion ≈ $741.47 Million	Rs32.66 Billion ≈ $353.21 Million	0.476x	+24.69%
2023-03-31	Rs61.98 Billion ≈ $670.29 Million	Rs23.68 Billion ≈ $256.09 Million	0.382x	+26.14%
2022-03-31	Rs59.53 Billion ≈ $643.79 Million	Rs18.03 Billion ≈ $194.99 Million	0.303x	-12.07%
2021-03-31	Rs58.37 Billion ≈ $631.27 Million	Rs20.11 Billion ≈ $217.45 Million	0.344x	+19.37%
2020-03-31	Rs48.23 Billion ≈ $521.61 Million	Rs13.92 Billion ≈ $150.52 Million	0.289x	-24.18%
2019-03-31	Rs47.24 Billion ≈ $510.92 Million	Rs17.98 Billion ≈ $194.46 Million	0.381x	+96.76%
2018-03-31	Rs46.23 Billion ≈ $499.93 Million	Rs8.94 Billion ≈ $96.70 Million	0.193x	-16.90%
2017-03-31	Rs43.51 Billion ≈ $470.50 Million	Rs10.13 Billion ≈ $109.52 Million	0.233x	-70.92%
2016-03-31	Rs33.89 Billion ≈ $366.56 Million	Rs27.13 Billion ≈ $293.43 Million	0.800x	+146.11%
2015-03-31	Rs24.91 Billion ≈ $269.39 Million	Rs8.10 Billion ≈ $87.62 Million	0.325x	+3.25%
2014-03-31	Rs19.03 Billion ≈ $205.78 Million	Rs5.99 Billion ≈ $64.82 Million	0.315x	+191.92%
2013-03-31	Rs14.22 Billion ≈ $153.82 Million	Rs1.53 Billion ≈ $16.60 Million	0.108x	-74.53%
2012-03-31	Rs11.97 Billion ≈ $129.49 Million	Rs5.07 Billion ≈ $54.87 Million	0.424x	+9.98%
2011-03-31	Rs10.24 Billion ≈ $110.74 Million	Rs3.95 Billion ≈ $42.67 Million	0.385x	+11.56%
2010-03-31	Rs8.31 Billion ≈ $89.87 Million	Rs2.87 Billion ≈ $31.04 Million	0.345x	-12.83%
2009-03-31	Rs6.51 Billion ≈ $70.39 Million	Rs2.58 Billion ≈ $27.89 Million	0.396x	-16.47%
2008-03-31	Rs5.10 Billion ≈ $55.11 Million	Rs2.42 Billion ≈ $26.14 Million	0.474x	+164.43%
2007-03-31	Rs4.10 Billion ≈ $44.37 Million	Rs735.97 Million ≈ $7.96 Million	0.179x	+81.59%
2006-03-31	Rs3.48 Billion ≈ $37.62 Million	Rs343.63 Million ≈ $3.72 Million	0.099x	+23.72%
2005-03-31	Rs3.16 Billion ≈ $34.12 Million	Rs251.96 Million ≈ $2.72 Million	0.080x	--

About Torrent Pharmaceuticals Limited

NSE:TORNTPHARM India Drug Manufacturers - Specialty & Generic

Market Cap

$18.98 Billion

Rs1.75 Trillion INR

Market Cap Rank

#1305 Global

#38 in India

Share Price

Rs4613.40

Change (1 day)

+0.73%

52-Week Range

Rs3553.40 - Rs5122.80

All Time High

Rs5122.80